FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097376100> ?p ?o ?g. }

• W3097376100 endingPage "s393" @default.
• W3097376100 startingPage "s392" @default.
• W3097376100 abstract "Background: In recent years, the historic declines in the incidence of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs) in the United States have slowed. We examined trends in the incidence of community-onset (CO) MRSA BSIs among hospitalized persons with and without substance-use diagnoses. Methods: Using data from >200 US hospitals reporting to the Premier Healthcare Database (PHD) during 2012–2017, we conducted a retrospective study among hospitalized persons aged ≥18 years. MRSA BSIs with substance use were defined as hospitalizations having both a blood culture positive for MRSA and at least 1 International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) or ICD-10-CM diagnostic code for substance use including opioids, cocaine, amphetamines, or other substances (excluding cannabis, alcohol, and nicotine). MRSA BSIs were considered community onset when a positive blood culture was collected within 3 days of admission. We assessed annual trends and described characteristics of CO MRSA BSI hospitalizations, stratified by substance use. Results : Of 20,049 MRSA BSIs from 2012 to 2017, 17,634 (88%) were CO. Overall, MRSA BSI incidence decreased 7%, from 178.5 to 166.2 per 100,000 hospitalizations during the study period; However, CO MRSA BSI rates remained stable (152.7 to 149.9 per 100,000 hospitalizations). Among CO MRSA BSIs, 1,838 (10%) were BSIs with substance-use diagnoses; the incidence of CO MRSA BSIs with substance use increased 236% (from 8.2 to 27.6 per 100,000 hospitalizations) and represented a greater proportion of the CO MRSA rate over the study period (Fig. 1). The incidence of CO MRSA BSIs without substance use decreased 15% (from 144.5 to 122.4 per 100,000 hospitalizations). Patients with CO MRSA BSIs with substance use were younger (median, 40 vs 65 years), more likely to be female (50% vs 40%), white (79% vs 69%), and to leave against medical advice (15% vs 1%). Among patients not leaving against medical advice, CO BSI patients with substance-use diagnoses had longer lengths of stay (median, 11 vs 9 days), lower in-hospital mortality (9% vs 14%), and higher hospitalization costs (median, $22,912 vs $17,468) compared to patients without substance-use diagnoses. Conclusions: Although the overall CO MRSA BSI rate remained unchanged from 2012 to 2017, infections with substance use diagnoses increased >3-fold, and infections without substance use diagnoses decreased. These data suggest that the emergence of MRSA associated with substance-use diagnoses threatens potential progress in reducing the incidence of CO MRSA infections. Additional strategies may be needed to prevent MRSA BSI in patients with substance-use diagnoses, and to maintain national progress in the reduction of MRSA infections overall. Funding: None Disclosures: None" @default.
• W3097376100 created "2020-11-09" @default.
• W3097376100 creator A5017654848 @default.
• W3097376100 creator A5035157202 @default.
• W3097376100 creator A5036433591 @default.
• W3097376100 creator A5042061244 @default.
• W3097376100 creator A5047095392 @default.
• W3097376100 creator A5055139508 @default.
• W3097376100 creator A5057843426 @default.
• W3097376100 creator A5078493598 @default.
• W3097376100 creator A5080633299 @default.
• W3097376100 date "2020-10-01" @default.
• W3097376100 modified "2023-09-25" @default.
• W3097376100 title "Substance Use Diagnoses Among Persons with Community-Onset Methicillin-Resistant Staphylococcus aureus Bloodstream Infections" @default.
• W3097376100 doi "https://doi.org/10.1017/ice.2020.1032" @default.
• W3097376100 hasPublicationYear "2020" @default.
• W3097376100 type Work @default.
• W3097376100 sameAs 3097376100 @default.
• W3097376100 citedByCount "0" @default.
• W3097376100 crossrefType "journal-article" @default.
• W3097376100 hasAuthorship W3097376100A5017654848 @default.
• W3097376100 hasAuthorship W3097376100A5035157202 @default.
• W3097376100 hasAuthorship W3097376100A5036433591 @default.
• W3097376100 hasAuthorship W3097376100A5042061244 @default.
• W3097376100 hasAuthorship W3097376100A5047095392 @default.
• W3097376100 hasAuthorship W3097376100A5055139508 @default.
• W3097376100 hasAuthorship W3097376100A5057843426 @default.
• W3097376100 hasAuthorship W3097376100A5078493598 @default.
• W3097376100 hasAuthorship W3097376100A5080633299 @default.
• W3097376100 hasBestOaLocation W30973761001 @default.
• W3097376100 hasConcept C118552586 @default.
• W3097376100 hasConcept C120665830 @default.
• W3097376100 hasConcept C121332964 @default.
• W3097376100 hasConcept C126322002 @default.
• W3097376100 hasConcept C167135981 @default.
• W3097376100 hasConcept C187212893 @default.
• W3097376100 hasConcept C194828623 @default.
• W3097376100 hasConcept C2426938 @default.
• W3097376100 hasConcept C2777052132 @default.
• W3097376100 hasConcept C2779443120 @default.
• W3097376100 hasConcept C2779489039 @default.
• W3097376100 hasConcept C2908647359 @default.
• W3097376100 hasConcept C40010229 @default.
• W3097376100 hasConcept C45827449 @default.
• W3097376100 hasConcept C501593827 @default.
• W3097376100 hasConcept C523546767 @default.
• W3097376100 hasConcept C54355233 @default.
• W3097376100 hasConcept C61511704 @default.
• W3097376100 hasConcept C71924100 @default.
• W3097376100 hasConcept C86803240 @default.
• W3097376100 hasConcept C89423630 @default.
• W3097376100 hasConcept C98274493 @default.
• W3097376100 hasConcept C99454951 @default.
• W3097376100 hasConceptScore W3097376100C118552586 @default.
• W3097376100 hasConceptScore W3097376100C120665830 @default.
• W3097376100 hasConceptScore W3097376100C121332964 @default.
• W3097376100 hasConceptScore W3097376100C126322002 @default.
• W3097376100 hasConceptScore W3097376100C167135981 @default.
• W3097376100 hasConceptScore W3097376100C187212893 @default.
• W3097376100 hasConceptScore W3097376100C194828623 @default.
• W3097376100 hasConceptScore W3097376100C2426938 @default.
• W3097376100 hasConceptScore W3097376100C2777052132 @default.
• W3097376100 hasConceptScore W3097376100C2779443120 @default.
• W3097376100 hasConceptScore W3097376100C2779489039 @default.
• W3097376100 hasConceptScore W3097376100C2908647359 @default.
• W3097376100 hasConceptScore W3097376100C40010229 @default.
• W3097376100 hasConceptScore W3097376100C45827449 @default.
• W3097376100 hasConceptScore W3097376100C501593827 @default.
• W3097376100 hasConceptScore W3097376100C523546767 @default.
• W3097376100 hasConceptScore W3097376100C54355233 @default.
• W3097376100 hasConceptScore W3097376100C61511704 @default.
• W3097376100 hasConceptScore W3097376100C71924100 @default.
• W3097376100 hasConceptScore W3097376100C86803240 @default.
• W3097376100 hasConceptScore W3097376100C89423630 @default.
• W3097376100 hasConceptScore W3097376100C98274493 @default.
• W3097376100 hasConceptScore W3097376100C99454951 @default.
• W3097376100 hasIssue "S1" @default.
• W3097376100 hasLocation W30973761001 @default.
• W3097376100 hasOpenAccess W3097376100 @default.
• W3097376100 hasPrimaryLocation W30973761001 @default.
• W3097376100 hasRelatedWork W1573937431 @default.
• W3097376100 hasRelatedWork W2009837019 @default.
• W3097376100 hasRelatedWork W2024876222 @default.
• W3097376100 hasRelatedWork W2055145594 @default.
• W3097376100 hasRelatedWork W2113194878 @default.
• W3097376100 hasRelatedWork W2123787004 @default.
• W3097376100 hasRelatedWork W2164393168 @default.
• W3097376100 hasRelatedWork W2172147404 @default.
• W3097376100 hasRelatedWork W2531729500 @default.
• W3097376100 hasRelatedWork W4290267115 @default.
• W3097376100 hasVolume "41" @default.
• W3097376100 isParatext "false" @default.
• W3097376100 isRetracted "false" @default.
• W3097376100 magId "3097376100" @default.
• W3097376100 workType "article" @default.